Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
B Lee Peterlin & Alan M Rapoport. (2007) Clinical pharmacology of the serotonin receptor agonist, zolmitriptan. Expert Opinion on Drug Metabolism & Toxicology 3:6, pages 899-911.
Read now
Read now
Robert Janknegt. (2007) Triptans in the treatment of migraine: drug selection by means of the SOJA method. Expert Opinion on Pharmacotherapy 8:sup1, pages S15-S30.
Read now
Read now
Articles from other publishers (28)
Mario Fernando Prieto Peres, Wanessa Alessandra Ruiz Scala & Ricardo Salazar. (2022) Comparison between metamizole and triptans for migraine treatment: a systematic review and network meta-analysis. Headache Medicine 12:3, pages 182-230.
Crossref
Crossref
Nathaniel Dusto & Danielle Perret Karimi. 2021. Migraine. Migraine
211
233
.
Hans-Christoph Diener, Cristina Tassorelli, David W Dodick, Stephen D Silberstein, Richard B Lipton, Messoud Ashina, Werner J Becker, Michel D Ferrari, Peter J Goadsby, Patricia Pozo-Rosich, Shuu-Jiun Wang & Jay Mandrekar. (2019) Guidelines of the International Headache Society for controlled trials of acute treatment of migraine attacks in adults: Fourth edition. Cephalalgia 39:6, pages 687-710.
Crossref
Crossref
Kristian Thorlund, Kabirraaj Toor, Ping Wu, Keith Chan, Eric Druyts, Elodie Ramos, Rahul Bhambri, Anne Donnet, Richard Stark & Peter J Goadsby. (2016) Comparative tolerability of treatments for acute migraine: A network meta-analysis. Cephalalgia 37:10, pages 965-978.
Crossref
Crossref
Haiyang Xu, Wei Han, Jinghua Wang & Mingxian Li. (2016) Network meta-analysis of migraine disorder treatment by NSAIDs and triptans. The Journal of Headache and Pain 17:1.
Crossref
Crossref
Paul Winner, Steven Linder & Andrew D. Hershey. (2015) Consistency of Response to Sumatriptan/Naproxen Sodium in a Randomized Placebo‐Controlled, Cross‐Over Study for the Acute Treatment of Migraine in Adolescence. Headache: The Journal of Head and Face Pain 55:4, pages 519-528.
Crossref
Crossref
Michael J. Marmura, Stephen D. Silberstein & Todd J. Schwedt. (2015) The Acute Treatment of Migraine in Adults: The American Headache Society Evidence Assessment of Migraine Pharmacotherapies. Headache: The Journal of Head and Face Pain 55:1, pages 3-20.
Crossref
Crossref
Sarah Bird, Sheena Derry & R Andrew Moore. (2014) Zolmitriptan for acute migraine attacks in adults. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Caroline Kerrison, Francesca Wright, Joseph Piper, Ram Kumar & Daniel B Hawcutt. (2014) Efficacy and tolerability of zolmitriptan oro-dispersible wafer in treatment of childhood migraine: Table 1. European Journal of Hospital Pharmacy 21:2, pages 84-86.
Crossref
Crossref
Stephen H. Landy, Roger K. Cady, Andrew Nelsen, Jonathan White & M. Chris Runken. (2014) Consistency of Return to Normal Function, Productivity, and Satisfaction Following Migraine Attacks Treated With Sumatriptan/Naproxen Sodium Combination. Headache: The Journal of Head and Face Pain 54:4, pages 640-654.
Crossref
Crossref
Carlo Lisotto & Giorgio Zanchin. (2012) Optimizing triptan therapy in clinical practice. Clinical Practice 9:3, pages 329-344.
Crossref
Crossref
Stephen H. Landy, M. Chris Runken, Christopher F. Bell, Rachel L. Higbie & Lisa S. Haskins. (2012) Examining the Interrelationship of Migraine Onset, Duration, and Time to Treatment. Headache: The Journal of Head and Face Pain 52:3, pages 363-373.
Crossref
Crossref
Anders Hougaard & Peer Tfelt-Hansen. (2010) Are the current IHS guidelines for migraine drug trials being followed?. The Journal of Headache and Pain 11:6, pages 457-468.
Crossref
Crossref
Alienor Berges, Christine Walls, Shelly E. Lener & Susan A. McDonald. (2010) Pharmacokinetics and tolerability of sumatriptan after single-dose administration of a fixed-dose combination tablet of sumatriptan/naproxen sodium 85/500 mg followed two hours later by subcutaneous sumatriptan 4- or 6-mg injection: A randomized, open-label, three-period crossover study in healthy volunteers. Clinical Therapeutics 32:6, pages 1165-1177.
Crossref
Crossref
D Valade. (2009) Early treatment of acute migraine: New evidence of benefits. Cephalalgia 29:3_suppl, pages 15-21.
Crossref
Crossref
D Valade. (2009) Early treatment of acute migraine: new evidence of benefits. Cephalalgia 29, pages 15-21.
Crossref
Crossref
RB Lipton, DW Dodick, JU Adelman, RG Kaniecki, SE Lener, JD White & AC Nelsen. (2009) Consistency of Response to Sumatriptan/Naproxen Sodium in a Placebo-Controlled, Crossover Study. Cephalalgia 29:8, pages 826-836.
Crossref
Crossref
Ninan T. Mathew, Stephen Landy, Stuart Stark, Gretchen E. Tietjen, Frederick J. Derosier, Jonathan White, Shelly E. Lener & Deo Bukenya. (2009) Fixed-Dose Sumatriptan and Naproxen in Poor Responders to Triptans With a Short Half-Life. Headache: The Journal of Head and Face Pain 49:7, pages 971-982.
Crossref
Crossref
Stephen LandyJonathan White, Shelly E. Lener & Susan A. McDonald. (2009) Fixed-dose sumatriptan/naproxen sodium compared with each monotherapy utilizing the novel composite endpoint of sustained pain-free/no adverse events. Therapeutic Advances in Neurological Disorders 2:3, pages 135-141.
Crossref
Crossref
A.A. KalanuriaB.L. Peterlin. (2009) A Review of the Pharmacokinetics, Pharmacodynamics and Efficacy of Zolmitriptan in the Acute Abortive Treatment of Migraine. Clinical Medicine. Therapeutics 1, pages CMT.S2056.
Crossref
Crossref
Sohan Parekh & Andy Jagoda. 2009. Emergency Department Analgesia. Emergency Department Analgesia
243
253
.
A Gendolla. (2008) Early Treatment in Migraine: How Strong is the Current Evidence?. Cephalalgia 28:2_suppl, pages 28-35.
Crossref
Crossref
S. D. SilbersteinL. K. MannixJ. GoldsteinJ. R. CouchS. C. ByrdM. H. AmesS. A. McDonaldS. E. Lener. (2008) Multimechanistic (sumatriptan-naproxen) early intervention for the acute treatment of migraine. Neurology 71:2, pages 114-121.
Crossref
Crossref
PJ Goadsby, G Zanchin, G Geraud, N de Klippel, S Diaz-Insa, H Gobel, L Cunha, N Ivanoff, M Falques & J Fortea. (2008) Early vs. Non-Early Intervention in Acute Migraine — ‘Act When Mild (AwM)’. A Double-Blind, Placebo-Controlled Trial of Almotriptan. Cephalalgia 28:4, pages 383-391.
Crossref
Crossref
Li-Chia Chen & Darren M. Ashcroft. (2007) Meta-Analysis of the Efficacy and Safety of Zolmitriptan in the Acute Treatment of Migraine. Headache: The Journal of Head and Face Pain 48:2, pages 236-247.
Crossref
Crossref
Frederick G. Freitag, Gary Finlayson, Alan M. Rapoport, Arthur H. Elkind, Merle L. Diamond, Jeffrey R. Unger, Alan C. Fisher, Robert B. Armstrong, Joseph F. Hulihan & Steven J. Greenberg. (2007) Effect of Pain Intensity and Time to Administration on Responsiveness to Almotriptan: Results from AXERT® 12.5 mg Time Versus Intensity Migraine Study (AIMS). Headache: The Journal of Head and Face Pain 47:4, pages 519-530.
Crossref
Crossref
Ninan T. Mathew, Gary Finlayson, Timothy R. Smith, Roger K. Cady, James Adelman, Lian Mao, Pamela Wright & Steven J. Greenberg. (2007)
Early Intervention With Almotriptan: Results of the AEGIS Trial (AXERT
�
Early Migraine Intervention Study)
. Headache: The Journal of Head and Face Pain 47:2, pages 189-198.
Crossref
Crossref
A. J. DOWSON, N. T. MATHEW & J. PASCUAL. (2006) Review of clinical trials using early acute intervention with oral triptans for migraine management. International Journal of Clinical Practice 60:6, pages 698-706.
Crossref
Crossref